GRO Biosciences is leveraging breakthrough technologies from computational protein design and synthetic biology to develop best-in-class protein therapeutics with enhanced properties. The company has established multiple genomically recoded strains of bacteria that can incorporate non-standard amino acids into proteins to confer increased potency, stability, and targeted delivery. GRO Biosciences is applying its technology platform to develop improved protein therapeutics for diabetes, growth disorders and autoimmunity. The company, founded by Dr. George Church, is located at the Harvard Life Lab, a shared laboratory space for high-potential life sciences and biotechnology startups founded by Harvard faculty, alumni, students, and postdoctoral scholars.
Select investors Digitalis Ventures, Innovation Endeavors, Pillar Companies, OS Fund, Heritage Provider Network, Rising Tide, Wilson Sonsini Goodrich & Rosati
Last update: May 17, 2018
Disclaimer: We can not guarantee that the information on this page is 100% correct. more